Literature DB >> 29043891

Rapidly progressive interstitial lung disease in a patient with anti-MDA5-positive amyopathic dermatomyositis.

A Nandy1, S Gaïni1,2,3, P Sore1,4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29043891     DOI: 10.1080/03009742.2017.1369155

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


× No keyword cloud information.
  3 in total

1.  Community-Acquired Pneumonia and Hospital-Acquired Pneumonia in Adult Patients with Idiopathic Inflammatory Myopathy: Outcome and Antibiotic Therapy.

Authors:  Junyu Liang; Chuanyin Sun; Liqin Xu; Guanhua Xu; Heng Cao; Jin Lin
Journal:  Rheumatol Ther       Date:  2020-12-28

Review 2.  Therapeutic Potential of Janus Kinase Inhibitors for the Management of Interstitial Lung Disease.

Authors:  Rongxiu Huo; Qianyu Guo; Junping Hu; Na Li; Rui Gao; Liangyu Mi; Zhaoliang Zhang; Hechao Liu; Zhiying Guo; Hanxi Zhao; Liyun Zhang; Ke Xu
Journal:  Drug Des Devel Ther       Date:  2022-04-02       Impact factor: 4.162

3.  Anti-MDA5 Amyopathic Dermatomyositis-A Diagnostic and Therapeutic Challenge.

Authors:  Anca Bobirca; Cristina Alexandru; Anca Emanuela Musetescu; Florin Bobirca; Anca Teodora Florescu; Magdalena Constantin; Tiberiu Tebeica; Alesandra Florescu; Sebastian Isac; Mihai Bojinca; Ioan Ancuta
Journal:  Life (Basel)       Date:  2022-07-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.